Literature DB >> 25229480

Paracrine factors secreted by umbilical cord-derived mesenchymal stem cells induce angiogenesis in vitro by a VEGF-independent pathway.

Pushpa Kuchroo1, Viral Dave, Ajay Vijayan, Chandra Viswanathan, Deepa Ghosh.   

Abstract

Improvement in angiogenesis using mesenchymal stem cells (MSCs) is evolving as an option in patients with vascular insufficiencies. The paracrine factors secreted by MSCs have been attributed to the angiogenic response. This study was conducted to identify the factors secreted by umbilical cord-derived MSCs (UCMSCs) that might play a role in angiogenesis. To this aim, we evaluated the presence of well known proangiogenic factors in the conditioned media (CM) derived from UCMSCs by ELISA. While vascular endothelial growth factor (VEGF), a well known angiogenic factor, was not detected in the CM, gene expression was nevertheless detected in these cells. Further investigations revealed the presence of soluble VEGF receptors (sVEGF-R1 and R2) that were capable of neutralizing exogenous VEGF. Human umbilical cord vein-derived endothelial cells exposed in vitro to CM, in comparison to control media, showed improved migration (P<0.007) and capillary-like network formation (P<0.001) with no significant change in endothelial cell proliferation. The angiogenic response observed with the paracrine factors secreted by UCMSC could be due to the presence of significant levels of a metalloprotease and matrix metalloproteases-2 (237.4±47.1 ng/10(6) cells). Data suggest that a VEGF-independent pathway is involved in the angiogenic response observed with endothelial cells in the presence of UCMSC-CM.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25229480      PMCID: PMC4313407          DOI: 10.1089/scd.2014.0184

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  71 in total

1.  Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms.

Authors:  T Kinnaird; E Stabile; M S Burnett; C W Lee; S Barr; S Fuchs; S E Epstein
Journal:  Circ Res       Date:  2004-01-22       Impact factor: 17.367

Review 2.  Mesenchymal stem cells: clinical applications and biological characterization.

Authors:  Frank P Barry; J Mary Murphy
Journal:  Int J Biochem Cell Biol       Date:  2004-04       Impact factor: 5.085

3.  Bone marrow stromal cells can provide a local environment that favors migration and formation of tubular structures of endothelial cells.

Authors:  Reinhard Gruber; Barbara Kandler; Phillip Holzmann; Margit Vögele-Kadletz; Udo Losert; Michael B Fischer; Georg Watzek
Journal:  Tissue Eng       Date:  2005 May-Jun

4.  Intravenously injected mesenchymal stem cells home to viable myocardium after coronary occlusion and preserve systolic function without altering infarct size.

Authors:  Robert A Boomsma; Paari Dominic Swaminathan; David L Geenen
Journal:  Int J Cardiol       Date:  2006-12-21       Impact factor: 4.164

5.  Mesenchymal stem cells inhibit both endogenous and exogenous MMPs via secreted TIMPs.

Authors:  Thomas P Lozito; Rocky S Tuan
Journal:  J Cell Physiol       Date:  2011-02       Impact factor: 6.384

6.  Direct comparison of human mesenchymal stem cells derived from adipose tissues and bone marrow in mediating neovascularization in response to vascular ischemia.

Authors:  Yeon Kim; Hoe Kim; Hyun Cho; Yong Bae; Kuen Suh; Jin Jung
Journal:  Cell Physiol Biochem       Date:  2007

7.  Establishment of a mesenchymal stem cell bank.

Authors:  Khushnuma Cooper; Chandra Viswanathan
Journal:  Stem Cells Int       Date:  2011-08-04       Impact factor: 5.443

8.  Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC.

Authors:  Ralf Hass; Cornelia Kasper; Stefanie Böhm; Roland Jacobs
Journal:  Cell Commun Signal       Date:  2011-05-14       Impact factor: 5.712

9.  Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects.

Authors:  Luis A Ortiz; Frederica Gambelli; Christine McBride; Dina Gaupp; Melody Baddoo; Naftali Kaminski; Donald G Phinney
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-18       Impact factor: 12.779

10.  Novel cell-free strategy for therapeutic angiogenesis: in vitro generated conditioned medium can replace progenitor cell transplantation.

Authors:  Stefano Di Santo; Zijiang Yang; Moritz Wyler von Ballmoos; Jan Voelzmann; Nicolas Diehm; Iris Baumgartner; Christoph Kalka
Journal:  PLoS One       Date:  2009-05-21       Impact factor: 3.240

View more
  27 in total

1.  Mesenchymal Stem Cell Therapy Alleviates Interstitial Cystitis by Activating Wnt Signaling Pathway.

Authors:  Miho Song; Jisun Lim; Hwan Yeul Yu; Junsoo Park; Ji-Youn Chun; Jaeho Jeong; Jinbeom Heo; Hyunsook Kang; YongHwan Kim; Yong Mee Cho; Seong Who Kim; Wonil Oh; Soo Jin Choi; Sung-Wuk Jang; Sanghyeok Park; Dong-Myung Shin; Myung-Soo Choo
Journal:  Stem Cells Dev       Date:  2015-04-09       Impact factor: 3.272

2.  Recent research on the mechanism of mesenchymal stem cells in the treatment of bronchopulmonary dysplasia.

Authors:  Ke-Jin Xie; Ming-Yue Dong; Jing-Xuan Bai
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-01-15

3.  Optimal Route for Mesenchymal Stem Cells Transplantation after Severe Intraventricular Hemorrhage in Newborn Rats.

Authors:  So Yoon Ahn; Yun Sil Chang; Dong Kyung Sung; Se In Sung; Hye Soo Yoo; Geun Ho Im; Soo Jin Choi; Won Soon Park
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

4.  Inhibition of Transforming Growth Factor-β Receptor signaling promotes culture expansion of undifferentiated human Endometrial Mesenchymal Stem/stromal Cells.

Authors:  Shanti Gurung; Jerome A Werkmeister; Caroline E Gargett
Journal:  Sci Rep       Date:  2015-10-13       Impact factor: 4.379

5.  Paracrine effects of human amniotic epithelial cells protect against chemotherapy-induced ovarian damage.

Authors:  Qiuwan Zhang; Shixia Bu; Junyan Sun; Minhua Xu; Xiaofen Yao; Kunyan He; Dongmei Lai
Journal:  Stem Cell Res Ther       Date:  2017-11-28       Impact factor: 6.832

Review 6.  Application of mesenchymal stem cell sheet to treatment of ischemic heart disease.

Authors:  Dehua Chang; Taibing Fan; Shuang Gao; Yongqiang Jin; Mingkui Zhang; Minoru Ono
Journal:  Stem Cell Res Ther       Date:  2021-07-07       Impact factor: 6.832

Review 7.  Hyperoxia-induced bronchopulmonary dysplasia: better models for better therapies.

Authors:  Kiersten Giusto; Heather Wanczyk; Todd Jensen; Christine Finck
Journal:  Dis Model Mech       Date:  2021-02-23       Impact factor: 5.758

8.  Role of VEGF-A in angiogenesis promoted by umbilical cord-derived mesenchymal stromal/stem cells: in vitro study.

Authors:  Irina Arutyunyan; Timur Fatkhudinov; Evgeniya Kananykhina; Natalia Usman; Andrey Elchaninov; Andrey Makarov; Galina Bolshakova; Dmitry Goldshtein; Gennady Sukhikh
Journal:  Stem Cell Res Ther       Date:  2016-03-22       Impact factor: 6.832

9.  Human bone marrow-derived and umbilical cord-derived mesenchymal stem cells for alleviating neuropathic pain in a spinal cord injury model.

Authors:  Mahmoud Yousefifard; Farinaz Nasirinezhad; Homa Shardi Manaheji; Atousa Janzadeh; Mostafa Hosseini; Mansoor Keshavarz
Journal:  Stem Cell Res Ther       Date:  2016-03-08       Impact factor: 6.832

10.  Endothelial Progenitor Cell Migration-Enhancing Factors in the Secretome of Placental-Derived Mesenchymal Stem Cells.

Authors:  Witchayaporn Kamprom; Pakpoom Kheolamai; Yaowalak U-Pratya; Aungkura Supokawej; Methichit Wattanapanitch; Chuti Laowtammathron; Sittiruk Roytrakul; Surapol Issaragrisil
Journal:  Stem Cells Int       Date:  2016-01-06       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.